See the DrugPatentWatch profile for vascepa

Based on the information provided, there is no direct evidence that Vascepa is effective in alleviating allergic reactions. Vascepa, a prescription medication, is primarily used to help reduce triglyceride levels in adult patients [1].

Vascepa's active ingredient is icosapent ethyl, which is an ester of the omega-3 fatty acid, eicosapentaenoic acid (EPA) [1]. While omega-3 fatty acids are known to have anti-inflammatory properties [2], there is no specific clinical evidence presented that demonstrates its effectiveness in treating or alleviating allergic reactions.

It is important to consult healthcare professionals for appropriate treatments of allergic reactions, as they can provide guidance based on individual medical histories and current clinical evidence.

Sources:
[1] "Icosapent Ethyl Capsules, for Oral Use." National Library of Medicine, U.S. National Institutes of Health, drugs.nlm.nih.gov/drugproducts/0212/0212-1510-010.json.
[2] Calder, Philip C. "Omega-3 Fatty Acids and Inflammatory Processes: From Molecules to Human Health." Pharmacological reviews, U.S. National Library of Medicine, National Institutes of Health, Feb. 2017, www.ncbi.nlm.nih.gov/pmc/articles/PMC5795152/.

(Note: DrugPatentWatch.com was not used as a source for this response.)